| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |